Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06690866

Negative Emotionality and Epigenetics During Puberty

Pubertal transition leads to enduring neuroendocrine changes along with changes in the epigenome. The prevalence of psychiatric disorders significantly increases in females compared to males after puberty. There is likely to be an interaction between epigenetics, hormones and neurophysiological processes during puberty, leading to the increased prevalence of mental disorders in females. This study aims to shed light on these interactions underlying the emerging sex differences after puberty. Specifically, it seeks to investigate the epigenetic modifications and subsequent changes in gene expression during the pubertal transition and their association with negative emotionality (e.g., acute stress response and depressive symptoms) at molecular, neuronal, subjective and physiological levels.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

8 year–17 year

Sex eligibility

Female

Study type

Observational

Primary location

University of Tuebingen; Department of Psychiatry & Psychotherapy; Tuebingen

Tübingen, Baden-Wurttemberg, 72076, Germany

Location status: Recruiting

Location contact

Mirac Nur Musaoglu, MD

CONTACT

Vanessa Nieratschker, Prof. Dr.

CONTACT

[email protected]

+497071 29-85523

Vanessa Nieratschker, Prof. Dr.

CONTACT

About this study

In order to investigate epigenetic and neuroimaging correlates of negative emotionality in pubertal girls, the study employs a cross-sectional design, enrolling 50 pre-pubescent girls (8-10 years) and 50 post-pubescent girls (15-17 years) as healthy participants. Comprehensive data will be collected using self- and parent-report questionnaires on pubertal status, prenatal complications, adverse life events, stress and coping mechanisms, mood and anxiety symptoms, gender identity, and reproductive health. To delve into the neuronal correlates of stress, participants will undergo (f)MRI and MIST. Additionally, physiological stress responses will be assessed through heart rate and skin conductance measurements. Participants will provide blood, saliva, and hair samples for hormone, methylation and expression analysis. DNA methylation analysis will be performed on whole blood and saliva samples using pyrosequencing, focusing on genes that are responsive to estrogen and genes involved in estrogen signaling, based on the previous literature reporting an overrepresentation of estrogen-responsive genes among the differentially methylated sites across the entire genome in girls during puberty. The effects of methylation on gene expression will be measured using reverse transcription real-time PCR. Cortisol levels will be assessed from saliva collected six times during MIST to evaluate the acute stress response and from hair to assess chronic stress. Sex steroids such as estrogen and progesterone from blood will be analyzed using LC-MS/MS. The study aims to provide insights into the intricate relationship between epigenetic modifications, gene expression and negative emotionality (e.g., stress reactivity and internalizing symptoms) during puberty in girls.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy girls
  • aged between 8-10 and having pubertal stage 1 or between 15-17 and having pubertal stage 5
  • normal body mass index according to age (between 5th and 85th percentile)
  • non-smoking
  • German language fluency
  • Attending age-appropriate schools

Exclusion criteria

  • neurological or psychiatric disease
  • medical problems such as hormonal, metabolic, developmental or chronic diseases (e.g., congenital disorders, precocious puberty, polycystic ovarian syndrome, diabetes or congestive heart failure)
  • any kind of hormonal, pharmacological or psychotropic treatment in the last three months
  • engaging in competitive/extreme sports

Additional exclusion criteria for MRI:

  • People with non-removable metal objects on or in the body
  • Tattoos (if not MRI-incompatible according to expert guidelines)
  • Pathological hearing or increased sensitivity to loud noises
  • Claustrophobia
  • Surgery less than three months ago
  • Moderate or severe head injury

Treatment and study plan

Stress

Behavioral

Montreal Imaging Stress Task is a stress paradigm in the scanner to examine neuronal correlates of acute psychosocial stress.

Primary outcomes

  1. DNA methylation differences between pre- and post-pubertal girls in candidate genes

    Time frame: Measured once after MRI measurement (approximately 30 minutes).

    DNA methylation (DNAm) leves in genes involved in estrogen signaling and neuronal estrogen responsive genes in blood and saliva

  2. Correlation between DNA methylation and neuronal activity during acute stress

    Time frame: Measured once: 3 runs of MIST lasting 20 minutes in total.

    Neuronal activity during acute stress is determined by the contrast differences between stress and control conditions assessed with task-based fMRI, Montreal Imaging Stress Task (MIST). The correlation between neuronal activity and DNA methylation. Comparing pre- and post-pubescent girls.

  3. The mediating role of sex steroids in DNA methlation and negative emotionality

    Time frame: Measured once for each part: 20 minutes for MIST, 30 minutes for blood and saliva collection, and 1 hour for questionnaires

    The mediating effect of estradiol, progesterone, testosterone and allopregnanolone levels in blood on the correlation between DNA methylation and indicators of negative emotionality (e.g., neuronal activity during stress (MIST task) and mood symptoms). Comparing pre- and post-pubescent girls

Secondary outcomes

  1. Correlation between DNA methylation and gene expression in candidate genes

    Time frame: Measured once after MRI measurement (approximately 30 minutes)

    The expression levels of genes involved in estrogen signaling and neuronal estrogen responsive genes in blood and saliva with RT-PCR. Correlation between DNA methlaytion and expression.

  2. Correlation between DNA methylation and HPA-axis response

    Time frame: Measured six times: 1 hour before MIST(1), just before(1) and after(1) MIST, and three times more in 20-minute intervals after MIST. Each saliva collection lasts approx. 2 minutes.

    Cortisol levels from saliva samples collected before and after MIST. Correlation between area under the curve (AUC) for cortisol and DNA methylation. Is there a mediating role of DNA methylation on the correlation between HPA-axis reactivity and negative emotionality (e.g., internalizing symptoms and stress processing)? Comparing pre- and post-pubescent girls.

  3. Correlation between DNA methylation and subjective stress response

    Time frame: Measured six times: 1 hour before MIST(1), just before(1) and after(1) MIST, and three times more in 20-minute intervals after MIST. Each rating takes approx. 10 minutes.

    Correlation between emotional ratings and stress levels assessed with each saliva sample before and after MIST and DNA methylation. Emotional ratings are based on self-assessment mannikin (SAM) which is a non-verbal pictorial tool. Stress levels evaluated with a stress thermometer using a scale of 1-10; 1 indicating not at all, 10 very strong. Is there a mediating effect of DNA methylation on the correlation between subjective stress response and negative emotionality (e.g., internalizing symptoms and stress processing). Comparing pre-and post-pubertal girls

  4. Correlation between DNA methylation and phsiological stress response

    Time frame: Measured once: 20 minutes for phsiological data during MRI measurement

    Correlation between HR, HRV and skin conductance changes during stress task (MIST) and DNA methylation. The interaction between physiological acute stress response and DNA methylation in relation to negative emotionality (e.g., internalizing symptoms and stress processing). Comparing pre-and post-pubertal girls

  5. Correlation between DNA methylation and functional connectivity

    Time frame: Measured once with resting-state functional MRI, approximately 10 mintes

    The correlation between functional connectivity in brain networks (e.g., default mode network (DMN) and salience network (SN)) and DNA methlaytion. The correlation between regions of interest (i.e., amygdala, anterior cingulate cortex, and hippocampus) activity during rest condition and DNA methylation. Is there a mediating role of DNA methylation on the correlation between resting-state neuronal activity and negative emotionality (e.g., mood and anxiety symptoms)? Comparing pre- and post-pubertal girls.

  6. Correlation between DNA methylation and brain gray matter structure

    Time frame: Measured once with MPRAGE MRI, approximately 10 minutes. Analyzed and reported over the course of the study, in average of 1 year

    The correlation between gray matter volumes obtained from anatomical T1-weighted images in regions of interest (i.e., amygdala, dorsolateral prefrontal cortex, putamen, anterior cingulate, hippocampus, ventral striatum) and DNA methylation. Is there a mediating role of DNA methylation on the correlation between region of interest gray matter volumes and negative emotionality (e.g., stress processing, mood and anxiety symptoms). Comparing pre- and post-pubescent girls.

Study contacts

Contact information is provided by the study sponsor or research team.

Birgit Derntl, Prof. Dr.

CONTACT

[email protected]

+497071 29-85437

Vanessa Nieratschker, Prof. Dr.

CONTACT

[email protected]

+497071-2985523

Sponsors and collaborators

Lead sponsor

International Research Training Group 2804

Other

Collaborators

  • German Research Foundation
  • University Hospital Tuebingen
  • Uppsala University

Registry information

Official study title

Negative Emotionality in Relation to Epigenetics of Estrogen Signaling During Puberty

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Nov 15, 2024
Registry last updated
Nov 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.